NOW® Celadrin® Lotion can help support joint and cartilage response to physical activity, exercise and postural stability. As evidenced by a 2005 University led, placebo controlled study, topical Celadrin® (7.5%) was shown to deliver esterified fatty acid carbons and other active ingredients capable of significantly reducing joint discomfort while increasing joint function and balance. (J Strength Cond Res. 2005 Feb; 19(1): 115-21).†
Celadrin and MSM Fact Sheet
Neil E. Levin, CCN, DANLA
LIKELY USERS: People lacking flexibility or mobility; People wanting temporary control of aches and pains; People wanting to reduce pro-inflammatory body chemicals
KEY INGREDIENT(S): Celadrin 500 mg.
MAIN PRODUCT FEATURES: CELADRIN is an all-natural proprietary matrix of esterified (cetylated) fatty acid carbons (EFAC) derived from tallow of USA-raised cattle. This product is developed through a proprietary process of esterifying oil & has been clinically tested. Celadrin promotes joint health by improving flexibility, painmanagement and mobility. The myristoleic acids and the cetylated forms may alter the 5-LOXenzyme and change the leukotriene production, inhibiting inflammatory compounds.
Celadrin may offer some noticeable benefits faster than other substances,like glucosamine and chondroitin. It is not a substitute for these important nutrients, though.
OTHER IMPORTANT ISSUES: MSM has synergistic abilities to reduce certain substances in the body which may affect inflammation.
AMOUNT and HOW TO USE: Three capsules a day, preferably with meals.
SYNERGISTS: Glucosamine, Chondroitin, MSM, Joint Support Products, Manganese, Vitamin C, other Antioxidants
CAUTIONS: Please notify your physician about your supplement use if you are using any drugs!
1. J Rheumatol. 2002 Aug;29(8):1708-12. Cetylated fatty acids improve knee function in patients with osteoarthritis. Hesslink R Jr, Armstrong D 3rd, Nagendran MV, Sreevatsan S, Barathur R.
2. Anticancer Res. 2003 Jan-Feb;23(1A):453-8. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Ebisuzaki K.
3. J Altern Complement Med. 2002 Apr;8(2):167-73. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. Barrager E, Veltmann JR Jr, Schauss AG, Schiller RN. (allergy related inflammation